Clinical studies of indinavir/ritonavir as salvage therapy
15 May 2000. Related: Conference reports, Drug resistance.
Conference reports
Indinavir plus ritonavir: might exposure to higher levels of indinavir overcome protease resistant HIV and prove useful to ‘rescue’ previously failed protease inhibitor based combinations?
15 May 2000. Related: Conference reports, Drug resistance.
First International Workshop in Clinical Pharmacology in HIV Therapy, 30-31 March 2000, Noordwijk, Netherlands
15 May 2000. Related: Conference reports.
TDM: standardisation and quality control
15 May 2000. Related: Conference reports.
TDM in clinical practice
15 May 2000. Related: Conference reports.
ATHENA – Early results from first randomised study of clinical benefits of TDM
15 May 2000. Related: Conference reports.
TDM for individualising dosing – practicality and efficacy for PIs and RTIs
15 May 2000. Related: Conference reports.
TDM and adherence
15 May 2000. Related: Conference reports.
Drug interactions: amprenavir, saquinavir, ABT-378/r (lopinavir/r), indinavir, efavirenz, ritonavir
15 May 2000. Related: Conference reports, PK and drug interactions.
L-Acetyl Carnitine (LAC) improves symptoms of peripheral neuropathy (PN): evidence for increases in cutaneous innervation
15 May 2000. Related: Conference reports, Side effects.
7th Conference on Retroviruses and Opportunistic Infections (ROI), January 30-February 2 2000, San Francisco
14 April 2000. Related: Conference reports.
Paediatrics: children are not small (or miniature) adults
14 April 2000. Related: Conference reports, Paediatric care.
HIV-positive women, pregnancy and newborns
14 April 2000. Related: Conference reports, Pregnancy, Drug resistance.
Flu-like symptoms of severe acute HIV infection develop after suspension of HAART
14 April 2000. Related: Conference reports.
Non-clade B virus: epidemiology, testing strategies and resistance
14 April 2000. Related: Conference reports, Drug resistance.